Today: 10 July 2026
Browse Category

Pharmaceuticals 15 May 2026 - 10 June 2026

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Holding Ltd. participation certificates listed on SIX traded up 1.07% at CHF 322.20 late Wednesday morning. Investors were eyeing a new $2.3 billion deal with Nurix Therapeutics, bringing Roche a late-stage blood-cancer asset. The stock line now trades as ROP after the company switched from the former ROG Genussscheine in March. Roche’s bearer shares are listed as RO.
10 June 2026
··
Oculis Stock Shock: Eye-Drop Trial Miss Sends Shares Sliding

Oculis Stock Shock: Eye-Drop Trial Miss Sends Shares Sliding

Oculis Holding AG shares fell sharply on Friday after the Swiss eye-drug developer said two late-stage trials of its OCS-01 eye drops failed to meet their main goal in diabetic macular edema, a diabetes-linked swelling in the retina that can damage sight. The company said it does not currently plan to pursue a U.S. Food and Drug Administration filing for the drug in that indication.
30 May 2026
··
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant shares closed 35.3% higher at $35.56 on Wednesday after the biotech company reported encouraging 16-week data for its experimental rheumatoid arthritis drug, IMVT-1402, a move that made the stock one of the day’s standout U.S. healthcare gainers. Roivant Sciences, Immunovant’s majority owner, also rose sharply, closing about 14.9% higher at $32.41.
20 May 2026
···
Pfizer Inc Looks to India, but Investors Hold Off

Pfizer Inc Looks to India, but Investors Hold Off

Pfizer Inc is looking to expand in India, focusing on cancer drugs, obesity therapies, vaccines and other specialty medicines as it looks to get back on track after its COVID-19 sales surge faded. Meenakshi Nevatia, who heads Pfizer in India, called the country a “must-win” and said “no company can be global if they’re not winning.” Nevatia also pointed to the need for faster product launches and better pricing for the Indian market.
15 May 2026
·
1 2 3 4 5 … 43

Stock Market Today

  • Brookfield Infrastructure (TSX:BIP.UN), Celestica (TSX:CLS) eye upside as AI data centre demand grows
    July 10, 2026, 11:06 AM EDT. Brookfield Infrastructure Partners (TSX:BIP.UN) posted Q1 2026 funds from operations of US$709 million, up 10% from last year. Data centre FFO jumped 46% to US$149 million, with gains from its U.S. bulk fiber network and data storage. Brookfield plans to put US$5 billion into behind-the-metre power and may IPO its Csquare data infrastructure business. Analysts expect FFO per share to rise from US$3.32 in 2025 to US$4.51 by 2028, hinting at close to 50% returns. Celestica (TSX:CLS) is seeing demand for Ethernet switches used by hyperscalers to manage new data centre networks and tackle network speed challenges needed for AI. The two Canadian stocks are well placed as AI shapes the data centre sector.
Go toTop